Skip to main content
Unchecking box will stop auto data updates
TSX Venture Real-Time Last Sale CAD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 8.280
Day High 8.560
Open:8.560
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
OrganiGram Holdings Inc is a Canada licensed producer of cannabis products. The company focuses on producing indoor-growth cannabis for patients and adult recreational consumers, as well as developing overseas business partnerships.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

StockCalc Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

ValuEngine Reports

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A
PR Newswire - Mon Jun 24, 5:00AM CDT
PR Newswire - CMTX
Mon Jun 24, 5:00AM CDT
Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1
Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A
PR Newswire - Mon Jun 24, 5:00AM CDT
PR Newswire - PRNW
Mon Jun 24, 5:00AM CDT
Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr 1
Legislators Reconsider Stance on Cannabis as the Industry Continues to Develop
PR Newswire - Thu Jun 20, 8:00AM CDT
PR Newswire - CMTX
Thu Jun 20, 8:00AM CDT
The support for cannabis legalization is reaching all-time highs every year as more countries continue to explore opportunities within the cannabis industry. In the early 2000s, approximately 31% of Americans supported the legalization of marijuana. By 2018, six in every ten Americans, or more precisely, 62% said that marijuana should be legalized, according to Pew Research Center's survey. Not surprisingly, most millennials are in favor of legalizing marijuana compared to other generations. Approximately 74% of millennials advocated for legalization, while 63% of Gen Xers and 54% of Baby Boomers supported the movement. Moreover, politicians have also begun shifting their stances on the matter. The survey highlighted that 69% of Democrats said marijuana should be legal while the Republican party remains split with 45% in favor and 51% opposed. Nevertheless, support among Republicans has risen from just 39% in 2015. The growing support comes as more and more countries and U.S. states continue to move towards legalization whether it's for medical or recreational use. While medical cannabis is currently more widely available compared to recreational cannabis, the North American region's recreational market is witnessing substantial growth. And although the U.S. still has not federally legalized cannabis, many speculate that it will follow in the footsteps of Canada and Uruguay in fully legalizing the plant. Overall, the U.S. has established its large market because of its early adoption of the plant, which dates back to the 1990s. Nonetheless, the Canadian cannabis market is still developing and maturing and the two countries are expected to continue to dominate the overall global market. According to data compiled by Mordor Intelligence, the global cannabis industry was valued at USD 14.5 Billion in 2018. By 2024, the market is expected to reach USD 89.1 Billion while registering a CAGR of 37% during the forecast period from 2019 to 2024. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB), Organigram Holdings Inc. (NASDAQ: OGI) (TSX-V: OGI), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE: CURA).
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 8.060 +3.47% increase
on 06/21/19
Period Open:10.090
Price movement based on the high, low and last over the given period.
10.620 -21.47% decrease
on 05/28/19
-1.750 (-17.34%) decrease
since 05/24/19
3-Month 8.060 +3.47% increase
on 06/21/19
Period Open:9.220
Price movement based on the high, low and last over the given period.
11.300 -26.19% decrease
on 05/21/19
-0.880 (-9.54%) decrease
since 03/22/19
52-Week 4.110 +102.92% increase
on 12/06/18
Period Open:5.720
Price movement based on the high, low and last over the given period.
11.300 -26.19% decrease
on 05/21/19
+2.620 (+45.80%) increase
since 06/22/18

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2019.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).